Cardiol Therapeutics logo

Cardiol Therapeutics Share Price (NASDAQ: CRDL)

$1.07

-0.02

(-1.83%)

Last updated on

Check the interactive Cardiol Therapeutics Stock chart to analyse performance

Cardiol Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.07
    Today's High:$1.09

    Day's Volatility :1.83%

  • 52 Weeks Low:$0.77
    52 Weeks High:$2.63

    52 Weeks Volatility :70.69%

Cardiol Therapeutics Stock Returns

PeriodCardiol Therapeutics IncIndex (Russel 2000)
3 Months
-13.31%
0.0%
6 Months
-1.38%
0.0%
1 Year
-43.42%
0.0%
3 Years
-6.52%
-4.7%

Cardiol Therapeutics Inc Key Stats

Check Cardiol Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.09
Open
$1.08
Today's High
$1.09
Today's Low
$1.07
Market Capitalization
$94.4M
Today's Volume
$437.1K
52 Week High
$2.63
52 Week Low
$0.7709
Revenue TTM
$0.0
EBITDA
$-40.2M
Earnings Per Share (EPS)
$-0.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-276.41%

Stock Returns calculator for Cardiol Therapeutics Stock including INR - Dollar returns

The Cardiol Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cardiol Therapeutics investment value today

Current value as on today

₹61,600

Returns

₹38,400

(-38.4%)

Returns from Cardiol Therapeutics Stock

₹43,684 (-43.68%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cardiol Therapeutics Stock

23%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cardiol Therapeutics Stock from India on INDmoney has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cardiol Therapeutics Inc

  • Name

    Holdings %

  • Tejara Capital Ltd

    3.95%

  • AdvisorShares Investments, LLC

    1.04%

  • Mmcap International Inc. Spc

    0.95%

  • UBS Group AG

    0.60%

  • Lion Street Advisors, LLC

    0.41%

  • CAMBRIDGE Invest RESEARCH ADVISORS, INC.

    0.25%

Analyst Recommendation on Cardiol Therapeutics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Cardiol Therapeutics(by analysts ranked 0 to 5 stars)

Cardiol Therapeutics Share Price Target

What analysts predicted

Upside of 730.86%

Target:

$8.89

Current:

$1.07

Cardiol Therapeutics share price target is $8.89, a slight Upside of 730.86% compared to current price of $1.07 as per analysts' prediction.

Cardiol Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, CRDL stock has moved down by -8.1%
  • CRDL vs NBIX (1 yr)

    In the last 1 year, Neurocrine Biosciences Inc. has given 9.9% return, outperforming this stock by 54.5%
  • CRDL vs HLN (3 yr)

    In the last 3 years, Haleon Plc Spon Ads has given 35.1% return, outperforming this stock by 46.3%

Cardiol Therapeutics Technicals Summary

Sell

Neutral

Buy

Cardiol Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cardiol Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cardiol Therapeutics Inc logo
-27.85%
-1.38%
-43.42%
-6.52%
-55.02%
Haleon Plc Spon Ads logo
1.5%
-7.33%
-3.49%
69.05%
32.32%
United Therapeutics Corporation logo
3.57%
-1.69%
-13.51%
34.83%
71.41%
Zoetis Inc. logo
6.13%
-8.28%
-14.8%
-1.88%
-3.48%
Neurocrine Biosciences Inc. logo
8.29%
21.94%
11.59%
32.16%
20.59%

About Cardiol Therapeutics Inc

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Organization
Cardiol Therapeutics
Employees
18
CEO
Mr. David G. Elsley MBA
Industry
Miscellaneous

Key Management of Cardiol Therapeutics Inc

NameTitle
Mr. David G. Elsley MBA
President, CEO & Director
Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA
CFO, Corporate Secretary & Director
Mr. Bernard Lim B.Sc.
Chief Operating Officer
Dr. Andrew Warwick Hamer M.D.
Chief Medical Officer and Head of Research & Development
Trevor Burns
Investor Relations
Mr. John A. Geddes BSCPT, MBA
Vice President of Corporate Development

Important FAQs about investing in CRDL Stock from India :

What is Cardiol Therapeutics share price today?

Cardiol Therapeutics share price today is $1.07 as on at the close of the market. Cardiol Therapeutics share today touched a day high of $1.09 and a low of $1.07.

What is the 52 week high and 52 week low for Cardiol Therapeutics share?

Cardiol Therapeutics share touched a 52 week high of $2.63 and a 52 week low of $0.77. Cardiol Therapeutics stock price today i.e. is closed at $1.07, lower by 59.32% versus the 52 week high.

How to invest in Cardiol Therapeutics Stock (CRDL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cardiol Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiol Therapeutics Shares that will get you 1.4019 shares as per Cardiol Therapeutics share price of $1.07 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cardiol Therapeutics Stock (CRDL) from India?

Indian investors can start investing in Cardiol Therapeutics (CRDL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cardiol Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cardiol Therapeutics share’s latest price of $1.07 as on August 30, 2025 at 1:29 am IST, you will get 9.3458 shares of Cardiol Therapeutics. Learn more about fractional shares .

What are the returns that Cardiol Therapeutics has given to Indian investors in the last 5 years?

Cardiol Therapeutics stock has given -55.02% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?